Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 262961, 6 pages
Clinical Study

Pain Management in the Elderly: Transdermal Fentanyl for the Treatment of Pain Caused by Osteoarthritis of the Knee and Hip

Department of Anaesthesiology and Intensive Care, Pain Clinic, University of Medicine, Chalubinskiego 1a, 50-368 Wroclaw, Poland

Received 8 April 2013; Revised 2 October 2013; Accepted 17 October 2013; Published 5 January 2014

Academic Editor: Roya Kelishadi

Copyright © 2014 Sylwester Mordarski. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


This study was designed to evaluate the utility of transdermal fentanyl (transdermal fentanyl, TDF) for the treatment of pain due to osteoarthritis (osteoarthritis, OA) of the knee and hip, which was not adequately controlled by nonopioid analgesics or weak opioids. WOMAC is a reliable, valid, and responsive multidimensional, self-administrated outcome measure designed specifically to evaluate patients with OA of the knee or hip. TDF significantly increased pain control and improved functioning and quality of life. Metoclopramide appeared to be of limited value in preventing nausea and vomiting.